Clik here to view.
The Medicare Part D Low-Income Subsidy Program: Experience to Date and Policy...
This brief explores the low-income subsidy (LIS) program and suggests that, while the program has made prescription drugs more affordable, the application and renewal process and market instability...
View ArticleClik here to view.
Medicare Prescription Drug Plans in 2010 and Key Changes Over Five Years:...
This brief examines five years of trends in Part D plans and highlights beneficiaries’ need to compare available plans to ensure that they obtain the most appropriate coverage. From the report: Since...
View ArticleClik here to view.
Prescription Drug Use Continues to Increase:U.S. Prescription Drug Data for...
The Centers for Disease Control and Prevention (CDC) released a study that found that the number of Americans taking at least one prescription drug monthly rose from 44 percent to 48 percent between...
View ArticleClik here to view.
Fixing Flaws In Medicare Drug Coverage That Prompt Insurers To Avoid...
This report from Health Affairs explores the problems with Medicare drug coverage that encourages insurers to avoid low-income patients. It also explores opportunities to fix these problems and...
View ArticleClik here to view.
Fixing Flaws In Medicare Drug Coverage That Prompt Insurers To Avoid...
This study by Health Affairs examines insurers of low-income patients participating in Medicare Part D. It concludes that insurers are not sufficiently reimbursed for relatively high pharmacy costs,...
View ArticleClik here to view.
Potential Federal and State-by-State Savings if Medicaid Pharmacy Programs...
On December 6, the Lewin Group released a study offering suggestions to improve cost efficiency in Medicaid pharmacy programs. By optimizing program management, the report identifies up to $30...
View ArticleClik here to view.
For What Diagnoses Are Psychotropic Medications Being Prescribed?: A...
This study published in CNS Drugs used the 2005 National Disease and Therapeutic Index (NDTI) to determine which diagnoses were predominately used when prescribing psychotropic medications, focusing...
View ArticleClik here to view.
Increasing the Cost-Effectiveness of Medicaid Drug Programs
The National Center for Policy Analysis (NCPA) has released a white paper arguing that the federal and state governments could save billions through changes to Medicaid pharmacy benefits management....
View ArticleClik here to view.
Implementation of Medicare Part D and Nondrug Medical Spending for Elderly...
A study published in the Journal of the American Medical Association (JAMA) found that that the Medicare Prescription Drug Program (Part D) was associated with a significant decline in non-drug...
View ArticleClik here to view.
Cost Shifting Debt Reduction to America’s Seniors: Medicare Part D Rebates...
On July 21, the American Action Forum (AAF) released a report, examining the effect of providing drug rebates similar to those employed in Medicaid to dual eligibles and beneficiaries of the Medicare...
View Article
